UBS Group AG - SIO GENE THERAPIES INC ownership

SIO GENE THERAPIES INC's ticker is SIOX and the CUSIP is 829399104. A total of 43 filers reported holding SIO GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SIO GENE THERAPIES INC
ValueSharesWeighting
Q4 2022$35,244
+3424.4%
80,100
+1669.4%
0.00%
Q3 2022$1,000
-95.0%
4,527
-91.8%
0.00%
Q2 2022$20,000
-23.1%
55,529
+169.4%
0.00%
Q4 2021$26,000
-75.9%
20,613
-50.3%
0.00%
Q1 2021$108,000
+315.4%
41,500
+341.4%
0.00%
Q4 2020$26,0009,4010.00%
Other shareholders
SIO GENE THERAPIES INC shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,969,987$8,108,0000.98%
Opaleye Management Inc. 2,000,000$5,258,0000.87%
Rubric Capital Management LP 3,000,000$8,190,0000.52%
Prosight Management, LP 256,115$699,0000.44%
ACT CAPITAL MANAGEMENT, LLC 185,000$506,0000.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,489,000$14,985,0000.22%
GSA CAPITAL PARTNERS LLP 363,887$993,0000.11%
KNOTT DAVID M 80,000$218,0000.08%
Hudson Bay Capital Management LP 1,540,000$4,204,0000.05%
APOGEM CAPITAL LLC 19,401$53,0000.03%
View complete list of SIO GENE THERAPIES INC shareholders